Opicapone as an Add-On to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase Iii, Double-Blind, Randomised, Placebo-Controlled Epsilon Trial
AuthID
P-00W-S6V
P-00W-S6V